Researchers have used base editing to rewrite specific genes in human embryos, targeting genes linked to heart disease and hemoglobin production.

While earlier CRISPR-based editing frequently caused unintended genetic damage, including snipping out wrong genetic bits or destroying entire chromosomes, base editing resulted in meticulously replaced individual DNA letters.